GlobeNewswire by notified

Demolition waste must be better recycled – SATO enhances its circular economy expertise at Vattuniemi demolition site

Share

SATO Corporation
Press release 14 June 2022 at 11:00 am

To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

Each year, some 1.6 million tonnes of demolition waste are generated in Finland. This waste could be recycled for use at other construction sites, yet legislation that is still evolving and a lack of shared practices in the industry hamper the implementation of the circular economy in construction. SATO is committed to promoting the circular economy by reducing its volume of construction waste through sorting and by diverting serviceable materials for re-use.

SATO is involved in the cluster programme for circular economy in construction launched by the City of Helsinki in summer 2021 to bring together industry operators to innovate ways to promote the circular economy. One of the sites for the cluster programme is the Vattuniemi district in Helsinki, where a major town plan amendment project involving multiple landowners is underway.

Considerable additional construction has been envisioned for Vattuniemi. When implemented, the new builds planned for Vattuniemi will necessitate extensive demolition. The building on a parcel of land held by SATO will also be taken down to make way for new construction.

“The first item on the agenda of any project of this kind is to figure out whether the building should be modernised or torn down. Before the decision is made, the matter must be examined from several points of view, including any future needs of people and the area,” Kirsi Ojala, SATO Project Development Manager explains.

Pre-demolition audit best way to ensure recycling of materials

SATO owns an office building from 1972 at the address Heikkiläntie 10 in Vattuniemi. In the current urban structure, the building is no longer ideally located for commercial purposes and it cannot be repurposed for housing. SATO intends to demolish the office building and replace it with a rental housing property for 80 residents.

As part of the cluster programme and its own sustainability work, SATO has carried out a detailed pre-demolition audit of the Vattuniemi demolition site already at the town planning stage. The audit revealed that the SATO building alone will yield around 2,800 tonnes of concrete, 145 tonnes of bricks and 84 tonnes of metals for recycling. The aim is to accumulate information on building elements and materials subject to demolition on a shared online platform. The shared platform will let participants learn of the materials available and their quantities well before reconstruction takes place in the area.

Anticipation is key when the goal is to recycle building elements. 

“Circular economy projects involve a great deal of exploratory work to determine the properties of the elements subject to demolition and the kinds of product approvals required for the demolition materials, and also to locate potential users for the materials. At the same time, it must be determined if the future users have any specific wishes regarding the materials so that the correct elements in the correct form can be provided,” says Ojala.

Materials can be re-used ‘as is’ and not only recycled as raw material

At circular economy sites, the goal is to re-use the elements of the building subject to demolition ‘as is’ rather than just convert them to raw material. The less processing the material requires, the better it is for the environment, too. 

As legislation and construction are constantly evolving, any changes in law or functionalities must be carefully taken into account in materials circulation.

“For example, is it advisable to relocate a lift to another building if the automation system of the lift at the demolition site is not up to current standards? Retaining the old lift ‘as is’ takes up space and increases costs, besides which old lifts are hard to re-sell. When disassembled into parts, up to 90-95% of the lift materials can fortunately be recycled,” describes Sami Pekuri, Project Engineer at SATO.

The various building elements can also be utilised ‘as is’ in lighter structures or repurposed completely, for example as stage props in the world of art. The option of using building elements as part of a separate storage building and structures to be built on the parcel of land will be examined at the Heikkiläntie site.

Circular economy relies on cooperation between industry operators

Industry operators must cooperate if torn-down building elements and even entire buildings are to be effectively circulated.

Besides expertise, also timetables must be coordinated and operations synchronised. It is important to create networks and encourage operators in the real estate and construction industry to innovate joint approaches so that the standards for the circular economy process can be established and it can be made a valuable resource for the entire construction industry.

For more information contact:

SATO Corporation, Project Development Manager Kirsi Ojala, phone +358 201 34 4011, kirsi.ojala@sato.fi
SATO Corporation, Project Engineer Sami Pekuri, phone +358 40 731 3580, sami.pekuri@sato.fi


SATO Corporation is an expert in sustainable rental housing and one of Finland’s largest rental housing providers. SATO owns around 25,000 rental homes in the Helsinki Metropolitan Area, Tampere and Turku.

SATO aims to provide an excellent customer experience and a comprehensive range of urban rental housing alternatives with good access to public transport and services. We promote sustainable development and work in open interaction with our stakeholders. SATO invests profitably, sustainably and with a long-term view. We increase the value of our assets through investments, divestments and repairs.

In 2021, SATO Group’s net sales totalled EUR 298.3 million, operating profit EUR 304.5 million and profit before taxes EUR 259.4 million. The value of SATO’s investment properties is around EUR 5 billion. www.sato.fi

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Basilea reports progress on the implementation of its strategy to focus on anti-infectives27.6.2022 07:15:00 CEST | Press release

ERADICATE phase 3 study exploring ceftobiprole for the treatment of patients with Staphylococcus aureus bacteremia (SAB) expected to report results shortlySeparate transactions for TTK/PLK1 inhibitor (BAL0891) and preclinical oncology projects expected to be concluded in H2 2022 No expansion of ongoing lisavanbulin clinical studies; exploring partnering opportunitiesDerazantinib rights to be transferred back to Merck & Co. by the end of 2022No material expenses related to oncology activities beyond 2022 and sustainable profitability expected in 2023Strategy implementation on track Ad hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, June 27, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today an update on the progress made in the implementation of its strategic focus on anti-infectives. David Veitch, Chief Executive Officer, stated: “We have made significant progress in the implementation of our new strategy. Wit

Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 202224.6.2022 22:05:00 CEST | Press release

REPORT –ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June24, 2022 – ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcedthat its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, including: Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2021;Allocation of the financial year's results;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2021, to Gil BEYEN, Chief Executive Officer and Jean-Paul KRESS, Chairman of the Board;Approval of the compens

Cleantech Building Materials: Results of Annual General Meeting24.6.2022 14:54:27 CEST | Press release

24 June 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM ISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC Results of Annual General Meeting The Annual General Meeting (“AGM”) of Cleantech Building Materials plc (“CBM” or the “Company”) was held in London earlier today, 24 June 2022. Details of the resolutions to be considered at the AGM were published in the Notice of AGM which was posted to Shareholders on 1 June 2022 and is available on the Company’s website: www.cbm-plc.com. All resolutions as set out in the Notice of AGM were duly passed without discussion. In particular, the following resolutions were passed at the AGM. The AGM resolved to authorise the directors of the Company to allot shares and grant rights to subscribe for, or convert any security, into shares. The directors of the Company sought authority for the purposes of section 551 of the Companies Act to exercise all the powers of the Company to allot shares and grant ri

Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia24.6.2022 13:13:19 CEST | Press release

With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least two prior tyrosine kinase inhibitor treatments1 Positive opinion based on data from pivotal Phase III ASCEMBL trial, showing a near doubling in major molecular response rate for patients treated with Scemblix® (asciminib) vs. Bosulif®* (bosutinib) (25.5% vs. 13.2%) and more than three times lower discontinuation rate due to adverse reactions (5.8% vs 21.1%) at 24 weeks1 CHMP recommendation comes after the approval of Scemblix by the US FDA and other countries’ regulatory authorities, potentially broadening access for more patients to Novartis transformative therapies in CML Basel, June 24, 2022 — Novartis today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing au

Clariant’s shareholders approve all agenda items24.6.2022 11:30:00 CEST | Press release

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Integrated Report and Group Consolidated Financial Statements for fiscal year 2021 approvedGünter von Au reelected as Chairman of the Board of DirectorsThree new candidates join the Board of Directors: Ahmed Mohamed Alumar, Roberto César Gualdoni, Naveena ShastriConfirmed distribution of CHF 0.40 per shareKPMG confirmed as statutory auditor from 2022 MUTTENZ, JUNE 24, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today held its 27th Annual General Meeting (AGM) where the shareholders approved all agenda items and resolutions as proposed by the Board of Directors. The AGM was held virtually, where shareholders were able to exercise their rights exclusively via the independent proxy. Overall, 698'945'298 shares or around 70.19 % of the share capital of Clariant were represented. Günter von Au was reelected as Chairman of the Board of Directors. Additionally, three new members were voted to join by a large majo